Loading clinical trials...
Loading clinical trials...
Rehabilitation After Admission in Intensive Care Unit for COVID-19: an Observational Study
France and especially the region "Grand Est" have been severely impacted by the COVID-19 pandemic. The first affected patients gradually began leaving the hospitalization sector and some of them required rehabilitation before returning home. Because it has only been studied for few months, COVID 19 possible impairment remain unknown, especially in patients who required admission in ICU and needed rehabilitation. In order to better understand the impact of the disease, the investigators wish to carry out a descriptive analysis of hospitalized patient in rehabilitation center for Post-Covid-19 rehabilitation after ICU. The purpose of this study was to describe the impairments and functional independency in patients addressed to a rehabilitation center after an ICU stay for COVID 19 and to explore the factors associated with their evolution.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Etablissement de santé Filieris
Freyming-Merlebach, Moselle, France
Hopital Legouest
Metz, Moselle, France
CHR Metz Thionville
Metz, Moselle, France
Start Date
April 1, 2020
Primary Completion Date
December 1, 2021
Completion Date
May 1, 2022
Last Updated
September 22, 2022
39
ACTUAL participants
Lead Sponsor
Centre Hospitalier Régional Metz-Thionville
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06355232